ADMA BIOLOGICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.81 USD | +1.04% |
|
+3.97% | +50.66% |
| 04-02 | ADMA Biologics, Inc. Announces Promotion of Kaitlin Kestenberg as Chief Operating Officer | CI |
| 03-26 | HC Wainwright Adjusts ADMA Biologics Price Target to $7.50 From $6, Maintains Buy Rating | MT |
Chart calendar ADMA Biologics, Inc.
4b46f.5A9ELQWK8a1rGoGfsftaCFUBf2BUqp_ERznvUZ4N7Hs.11gPd07bhfwnVfL6-6gNRhRWGVMH2e2BBgnfPqdMjk7TewgAdfLI1yRetQ~678cb18e2c0c3885e4638c881391e95c
Upcoming events on ADMA Biologics, Inc.
Past events on ADMA Biologics, Inc.
| 06/03/2024 16:35 | Raymond James Institutional Investor Conference |
| 28/02/2024 21:30 | Q4 2023 Earnings Call |
| 28/02/2024 21:05 | Q4 2023 Earnings Release |
| 08/11/2023 21:30 | Q3 2023 Earnings Call |
| 08/11/2023 21:05 | Q3 2023 Earnings Release |
| 09/08/2023 21:30 | Q2 2023 Earnings Call |
| 09/08/2023 21:05 | Q2 2023 Earnings Release |
| 06/06/2023 15:00 | Annual General Meeting |
| 10/05/2023 21:30 | Q1 2023 Earnings Call |
| 10/05/2023 21:05 | Q1 2023 Earnings Release |
| 23/03/2023 20:30 | Q4 2022 Earnings Call |
| 23/03/2023 20:05 | Q4 2022 Earnings Release |
| 09/11/2022 21:30 | Q3 2022 Earnings Call |
| 09/11/2022 21:05 | Q3 2022 Earnings Release |
| 10/08/2022 21:30 | Interim 2022 Earnings Call |
| 10/08/2022 21:05 | Interim 2022 Earnings Release |
| 21/06/2022 15:00 | Annual General Meeting |
| 11/05/2022 21:30 | Q1 2022 Earnings Call |
| 11/05/2022 21:05 | Q1 2022 Earnings Release |
| 02/04/2022 17:45 | ASCENIV Symposium |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 29,3 28,6 2.45% | 42,2 42,1 0.38% | 80,9 77,0 5.12% | 154 154 0.29% | 258 256 0.69% | 334 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 40,3 35,0 15.17% | 103 |
|
EBIT Million USD | Released Forecast Spread | -41,4 -42,0 1.4% | -64,9 -61,0 -6.39% | -58,4 -60,0 2.66% | -39,4 -41,3 4.75% | 21,6 19,1 13.15% | 82,1 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -48,3 -48,3 0.14% | -75,7 -72,4 -4.58% | -55,0 -72,7 24.3% | -65,9 -65,0 -1.34% | -28,2 -4,58 -516.84% | 67,4 |
|
Net income Million USD | Released Forecast Spread | -48,3 -48,3 0.14% | -75,7 -72,4 -4.58% | -71,6 -72,7 1.38% | -65,9 -65,0 -1.34% | -28,2 -4,58 -516.84% | 67,4 |
|
EPS USD | Released Forecast Spread | -0,89 -0,90 0.56% | -0,88 -0,86 -2.8% | -0,51 -0,52 0.97% | -0,33 -0,33 0% | -0,13 -0,02 -550% | 0,30 |
| Announcement Date | 12/03/20 | 25/03/21 | 24/03/22 | 23/03/23 | 28/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 26,4 21,8 21.21% | 29,1 28,2 3.39% | 33,9 31,8 6.58% | 41,1 34,5 19.05% | 50,0 48,1 3.97% | 56,9 53,4 6.56% | 60,1 55,5 8.33% | 67,3 62,1 8.29% | 73,9 73,0 1.28% | 77,3 | 81,3 | 85,7 | 89,7 |
|
EBITDA Million USD | Released Forecast Spread | 6,43 4,60 39.85% | 12,7 8,10 57.4% | 18,6 13,4 39.33% | 19,1 | 22,1 | 32,7 | 29,4 | ||||||
|
EBIT Million USD | Released Forecast Spread | -13,2 -14,8 10.67% | -14,8 -13,3 -11.39% | -9,17 -12,1 23.92% | -9,32 -11,3 17.44% | -6,06 -9,13 33.63% | -0,81 -4,44 81.7% | -0,47 -0,13 -271.77% | 8,69 3,70 134.77% | 14,2 11,7 21.48% | 16,4 | 19,2 | 26,2 | 23,9 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -16,6 -17,7 5.94% | -25,0 -16,9 -48.41% | -13,8 -15,5 11.05% | -14,9 -16,2 8.15% | -12,2 -14,2 13.8% | -6,79 -9,27 26.74% | -6,37 -5,32 -19.8% | 2,57 -1,55 265.76% | -17,6 6,07 -390.62% | 12,4 | 15,4 | 22,6 | 20,5 |
|
Net income Million USD | Released Forecast Spread | -16,6 -17,7 5.94% | -25,0 -16,9 -48.41% | -13,8 -15,5 11.05% | -14,9 -16,2 8.15% | -12,2 -14,2 13.8% | -6,79 -9,22 26.33% | -6,37 -5,32 -19.8% | 2,57 -1,55 265.76% | -17,6 6,07 -390.62% | 12,4 | 15,4 | 22,6 | 20,5 |
|
EPS USD | Released Forecast Spread | -0,07 -0,10 26.32% | -0,13 -0,09 -52.94% | -0,07 -0,08 12.5% | -0,08 -0,08 4% | -0,06 -0,07 14.29% | -0,03 -0,04 29.41% | -0,03 -0,03 -20% | 0,01 -0,01 233.33% | -0,08 0,03 -420% | 0,06 | 0,07 | 0,10 | 0,09 |
| Announcement Date | 24/03/22 | 11/05/22 | 10/08/22 | 09/11/22 | 23/03/23 | 10/05/23 | 09/08/23 | 08/11/23 | 28/02/24 | - | - | - | - |
| 06/05/2024 12:00 | AXSOME THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 06/05/2024 | BIOTEST AG: Q1 2024 Earnings Release |
| 06/05/2024 | AVIDITY BIOSCIENCES, INC.: Q1 2024 Earnings Release (Projected) |
| 06/05/2024 | APELLIS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 07/05/2024 07:00 | BIOGAIA AB: Q1 2024 Earnings Release |
| 07/05/2024 12:30 | INTRA-CELLULAR THERAPIES, INC.: Q1 2024 Earnings Release |
| 07/05/2024 | CATALYST PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 07/05/2024 | ZAI LAB LIMITED: Q1 2024 Earnings Release |
| 08/05/2024 12:55 | VERICEL CORPORATION: Q1 2024 Earnings Release |
| 08/05/2024 | NXERA PHARMA CO., LTD.: Q1 2024 Earnings Release |
Past sector events for ADMA Biologics, Inc.
| 02/05/2024 21:05 | TWIST BIOSCIENCE CORPORATION: Q2 2024 Earnings Release |
| 02/05/2024 12:50 | ARBUTUS BIOPHARMA CORPORATION: Q1 2024 Earnings Release |
| 02/05/2024 12:30 | BRIDGEBIO PHARMA, INC.: Q1 2024 Earnings Release |
| 01/05/2024 | SK BIOSCIENCE CO.,LTD.: Q1 2024 Earnings Release |
| 30/04/2024 12:00 | INCYTE CORPORATION: Q1 2024 Earnings Release |
| 29/04/2024 | SHANDONG SINOBIOWAY BIOMEDICINE CO., LTD.: Q4 2023 Earnings Release |
| 29/04/2024 | SHANDONG SINOBIOWAY BIOMEDICINE CO., LTD.: Q1 2024 Earnings Release |
| 29/04/2024 | BLOOMAGE BIOTECHNOLOGY CORPORATION LIMITED: Q4 2023 Earnings Release |
| 29/04/2024 22:53 | SINOVAC BIOTECH LTD.: Q4 2023 Earnings Release |
| 28/04/2024 | SHANGHAI OPM BIOSCIENCES CO., LTD.: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ADMA Stock
- Calendar ADMA Biologics, Inc.
